Quick Summary
- Intel shares climbed 2.8% during Monday’s premarket session, extending a massive 24% rally from Friday following its first-quarter earnings release.
- The company delivered Q1 earnings per share of $0.29, obliterating Wall Street’s expectation of just $0.01, while revenue reached $13.58B versus the $12.32B consensus.
- Management highlighted “unprecedented” demand for AI server CPUs as the primary catalyst behind the outperformance.
- UBS lifted its price target to $83 while maintaining a Neutral stance, noting Intel’s elevated forward P/E multiple of 71x compared to AMD’s 42x and Nvidia’s 23x.
- Intel’s foundry ambitions received validation as Tesla confirmed plans to utilize the company’s 14A manufacturing process for Terafab AI chips.
Intel (INTC) is experiencing a dramatic resurgence. Shares advanced 2.8% in Monday’s premarket session to $84.84, extending Friday’s explosive 24% rally triggered by a first-quarter earnings report that exceeded even the most optimistic forecasts.
The financial results spoke volumes. Intel posted first-quarter earnings of $0.29 per share compared to the meager $0.01 consensus forecast. Revenue totaled $13.58 billion, significantly surpassing Wall Street’s projection of $12.32 billion. This represented a 7.4% increase compared to the prior-year period.
The chipmaker attributed the blowout performance to exceptional demand for processors deployed in AI server infrastructure. Executives characterized current CPU demand for artificial intelligence applications as “unprecedented.”
Intel further energized investors with optimistic second-quarter guidance, projecting EPS of $0.20 alongside revenue expectations that comfortably exceeded analyst models.
Shares have experienced a remarkable transformation over the trailing twelve months, surging more than fourfold. The stock opened Monday at $82.37, approaching its 52-week peak of $85.22. Twelve months earlier, it languished near $18.97.
Wall Street Weighs In
Several research firms swiftly adjusted their positions following the earnings announcement. HSBC elevated its rating from Hold to Buy while boosting its price objective from $50 to $95. Raymond James shifted from Hold to Moderate Buy. Barclays increased its target to $65 from $45 while maintaining Equal Weight. The consensus recommendation currently stands at Hold with a mean price target of $72.98.
However, not all analysts are embracing the rally wholeheartedly. UBS analyst Timothy Arcuri raised his price target to $83 from $65 but preserved his Neutral rating. He highlighted concerns about Intel’s forward price-to-earnings ratio hovering around 71x, appearing expensive relative to AMD’s 42x and Nvidia‘s 23x.
“We have underestimated how much the market was willing to overlook a lack of earnings power,” Arcuri wrote.
It’s a legitimate concern worth considering. The current valuation demands flawless execution going forward.
Manufacturing Momentum Builds
Intel received encouraging news on the foundry front when Tesla indicated its intention to leverage Intel’s 14A process technology for manufacturing its Terafab AI chips. Landing such a prominent customer provides meaningful validation for Intel’s manufacturing turnaround narrative.
Institutional investors have been accumulating shares. Vanguard expanded its holdings by 3.5% during the fourth quarter, now owning more than 404 million shares. Capital World Investors increased its stake by 32.5% in Q3. Institutional ownership currently comprises 64.53% of outstanding shares.
Short interest climbed approximately 20.9% in mid-April to roughly 144 million shares, representing about 2.9% of the float. The short-interest ratio remains modest at approximately 1.2 days.
One insider transaction went against the grain. EVP April Miller Boise divested 20,000 shares in February at $49.05, trimming her holdings by roughly 15%.
Intel’s market capitalization now stands at approximately $411 billion. For the complete fiscal year, the analyst consensus projects EPS of $0.08.



